Cite
HARVARD Citation
Baldini, C. et al. (2022). Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials. European journal of cancer. pp. 98-107. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Baldini, C. et al. (2022). Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials. European journal of cancer. pp. 98-107. [Online].